In vitro diagnostics account for only about 2% of total healthcare spending yet influence over 66% of clinical decision-making
More than 75% of the 7 lakh annual cancer deaths in India can be prevented with early screening and diagnosis
Remote monitoring can reduce Hospitalisations and deaths in heart failure patients by 29% and 20% respectively
Studies have shown that India’s health system has a persistent challenge of limited resources – including cost of care, accessible quality care, trained professionals, and lag in uptake of effective technology solutions. Limited personnel and infrastructure constraints cause long turnaround times for diagnosis and initiation of treatment contributing to the rising disease burden, out of pocket expenditures and worsening health conditions. The window for early interventions is missed, which is critical for prevention and management of most of the chronic illnesses.
OVERVIEW
Pfizer INDovation: NIPER-A Edition, with Department of Pharmaceuticals, NITI Aayog and Social Alpha as anchor partners is designed to support start-ups building high-quality affordable diagnostics.
Focus Areas
- To tackle the problem of limited resources, the program is looking for innovative screening and diagnostic tools that have quick turnaround time for tests, requires minimum or no infrastructure to set up or operate and has less dependence on skilled professionals to use/run the tests. The solutions should be affordable, high in quality and accurate.
- For improvement of health outcomes, care should be accessible beyond hospitals as well. To enable continuum of care at home, the program aims to support development of solutions that enable remote monitoring of patients’ conditions, quick clinical response to episodes and high compliance to care protocols.